Research has shown that psychedelics, such as LSD have profound anti-inflammatory properties. A new phase 1 double-blind, placebo-controlled, randomized study suggests safety of microdosing LSD and support further clinical development of LSD for the treatment and prevention of Alzheimer’s disease.

Research has shown that psychedelics, such as LSD have profound anti-inflammatory properties. A new phase 1 double-blind, placebo-controlled, randomized study suggests safety of microdosing LSD and support further clinical development of LSD for the treatment and prevention of Alzheimer’s disease.: https://ift.tt/34G32yY Read more... https://ift.tt/35IopAQ